Home LiteratureArticle Details
PMID: 15539461 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Finding new components of the target of rapamycin (TOR) signaling network through chemical genetics and proteome chips.

Huang J, Zhu H, Haggarty SJ, Spring DR, Hwang H, Jin F, Snyder M, Schreiber SL

Abstract

The TOR (target of rapamycin) proteins play important roles in nutrient signaling in eukaryotic cells. Rapamycin treatment induces a state reminiscent of the nutrient starvation response, often resulting in growth inhibition. Using a chemical genetic modifier screen, we identified two classes of small molecules, small-molecule inhibitors of rapamycin (SMIRs) and small-molecule enhancers of rapamycin (SMERs), that suppress and augment, respectively, rapamycin's effect in the yeast Saccharomyces cerevisiae. Probing proteome chips with biotinylated SMIRs revealed putative intracellular target proteins, including Tep1p, a homolog of the mammalian PTEN (phosphatase and tensin homologue deleted on chromosome 10) tumor suppressor, and Ybr077cp (Nir1p), a protein of previously unknown function that we show to be a component of the TOR signaling network. Both SMIR target proteins are associated with PI(3,4)P2, suggesting a mechanism of regulation of the TOR pathway involving phosphatidylinositides. Our results illustrate the combined use of chemical genetics and proteomics in biological discovery and map a path for creating useful therapeutics for treating human diseases involving the TOR pathway, such as diabetes and cancer.

MeSH Terms
Humans Jurkat Cells Models, Biological Protein Array Analysis Protein Kinases/genetics,metabolism Proteomics Saccharomyces cerevisiae/drug effects,genetics,metabolism Saccharomyces cerevisiae Proteins/genetics,metabolism Signal Transduction Sirolimus/pharmacology TOR Serine-Threonine Kinases
Chemicals
Saccharomyces cerevisiae Proteins Protein Kinases MTOR protein, human TOR Serine-Threonine Kinases Sirolimus
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Huang Jing
Howard Hughes Medical Institute, Harvard Institute of Chemistry and Cell Biology, and Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138, USA. [email protected]
Zhu Heng
Haggarty Stephen J
Spring David R
Hwang Heejun
Jin Fulai
Snyder Michael
Schreiber Stuart L
References (32)
32 references, click to expand
  1. The TOR signaling cascade regulates gene expression in response to nutrients.
    Genes Dev. 1999 Dec 15;13(24):3271-9 PMID: 10617575
  2. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy.
    Science. 1999 Sep 10;285(5434):1733-7 PMID: 10481009
  3. A chemical switch for inhibitor-sensitive alleles of any protein kinase.
    Nature. 2000 Sep 21;407(6802):395-401 PMID: 11014197
  4. Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen.
    Science. 1999 Oct 29;286(5441):971-4 PMID: 10542155
  5. From molecular to modular cell biology.
    Nature. 1999 Dec 2;402(6761 Suppl):C47-52 PMID: 10591225
  6. The TOR signalling pathway controls nuclear localization of nutrient-regulated transcription factors.
    Nature. 1999 Dec 9;402(6762):689-92 PMID: 10604478
  7. Rapamycin-modulated transcription defines the subset of nutrient-sensitive signaling pathways directly controlled by the Tor proteins.
    Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):14866-70 PMID: 10611304
  8. TEP1, the yeast homolog of the human tumor suppressor gene PTEN/MMAC1/TEP1, is linked to the phosphatidylinositol pathway and plays a role in the developmental process of sporulation.
    Proc Natl Acad Sci U S A. 2000 Nov 7;97(23):12672-7 PMID: 11070083
  9. Integrated genomic and proteomic analyses of a systematically perturbed metabolic network.
    Science. 2001 May 4;292(5518):929-34 PMID: 11340206
  10. An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten+/- mice.
    Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10320-5 PMID: 11504907
  11. Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR.
    Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10314-9 PMID: 11504908
  12. Linking molecular therapeutics to molecular diagnostics: inhibition of the FRAP/RAFT/TOR component of the PI3K pathway preferentially blocks PTEN mutant cells in vitro and in vivo.
    Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10031-3 PMID: 11526226
  13. Global analysis of protein activities using proteome chips.
    Science. 2001 Sep 14;293(5537):2101-5 PMID: 11474067
  14. Rapamycin's resurrection: a new way to target the cancer cell cycle.
    J Natl Cancer Inst. 2001 Oct 17;93(20):1517-9 PMID: 11604470
  15. Mechanisms of resistance to rapamycins.
    Drug Resist Updat. 2001 Dec;4(6):378-91 PMID: 12030785
  16. The immunosuppressant rapamycin mimics a starvation-like signal distinct from amino acid and glucose deprivation.
    Mol Cell Biol. 2002 Aug;22(15):5575-84 PMID: 12101249
  17. Functional profiling of the Saccharomyces cerevisiae genome.
    Nature. 2002 Jul 25;418(6896):387-91 PMID: 12140549
  18. Transcriptional regulatory networks in Saccharomyces cerevisiae.
    Science. 2002 Oct 25;298(5594):799-804 PMID: 12399584
  19. Tor signalling in bugs, brain and brawn.
    Nat Rev Mol Cell Biol. 2003 Feb;4(2):117-26 PMID: 12563289
  20. Protein analysis on a proteomic scale.
    Nature. 2003 Mar 13;422(6928):208-15 PMID: 12634794
  21. Raptor and mTOR: subunits of a nutrient-sensitive complex.
    Curr Top Microbiol Immunol. 2004;279:259-70 PMID: 14560962
  22. Proteomics: where's Waldo in yeast?
    Nature. 2003 Oct 16;425(6959):671-2 PMID: 14562083
  23. Activation of the RAS/cyclic AMP pathway suppresses a TOR deficiency in yeast.
    Mol Cell Biol. 2004 Jan;24(1):338-51 PMID: 14673167
  24. Glucose induces cAMP-independent growth-related changes in stationary-phase cells of Saccharomyces cerevisiae.
    Proc Natl Acad Sci U S A. 1991 Jul 1;88(13):5724-8 PMID: 1648229
  25. Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast.
    Science. 1991 Aug 23;253(5022):905-9 PMID: 1715094
  26. PIK-related kinases: DNA repair, recombination, and cell cycle checkpoints.
    Science. 1995 Oct 6;270(5233):50-1 PMID: 7569949
  27. Exploring the metabolic and genetic control of gene expression on a genomic scale.
    Science. 1997 Oct 24;278(5338):680-6 PMID: 9381177
  28. TOR signalling and control of cell growth.
    Curr Opin Cell Biol. 1997 Dec;9(6):782-7 PMID: 9425342
  29. Cell wall integrity modulates RHO1 activity via the exchange factor ROM2.
    EMBO J. 1998 Apr 15;17(8):2235-45 PMID: 9545237
  30. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate.
    J Biol Chem. 1998 May 29;273(22):13375-8 PMID: 9593664
  31. The lipid phosphatase activity of PTEN is critical for its tumor supressor function.
    Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13513-8 PMID: 9811831
  32. Functional discovery via a compendium of expression profiles.
    Cell. 2000 Jul 7;102(1):109-26 PMID: 10929718
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
2004-11-23
Epub
2004-00-11
Pages
16594-9
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC527135
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]